Keynote Address--the Innovator's Prescription: An Examination of the Future of Health Care Through the Lenses of Disruptive Innovation (Conference News) Keynote Address--the Innovator's Prescription: An Examination of the Future of Health Care Through the Lenses of Disruptive Innovation (Conference News)

Keynote Address--the Innovator's Prescription: An Examination of the Future of Health Care Through the Lenses of Disruptive Innovation (Conference News‪)‬

Archives of Pathology & Laboratory Medicine, 2009, April, 133, 4

    • 2,99 €
    • 2,99 €

Publisher Description

I want to give credit where it is due and mention that during the past 3 years I have had the privilege of working with Professor Clayton Christensen at the Harvard Business School (Boston, Massachusetts), and his ideas and groundbreaking research are really the foundation of many of the concepts that I am going to present to you. The whole idea of disruptive innovation comes from the world of business, and it is rooted in the observation that if you were to go through and scan through the annals of business history, most of the companies that were at one time considered to be unassailably successful, within a decade or two, found themselves running in the middle of the pack, or worse, at the bottom of the heap. And this observation really did not make sense at first because at one time when these companies were high flyers, all of the trade magazines and leaders of the industry commended the management of these companies, talking about how brilliant they were in leading these companies to the top of their business, and yet a decade or two later when these same managers were in charge, they were criticized for running their companies into the ground. It did not make sense that it happened with such frequency and regularity that all of a sudden managers could suddenly become stupid and turn their companies to dust. The observation was made in Professor Christensen's initial research that it was actually the principles of good management that were being taught at Harvard and other business schools around the country and the world that were causing these successful businesses to fail. The initial message that came out of the first book, The Innovator's Dilemma, was that if you somehow became wildly successful by doing everything right, you were doomed. (1) (Unfortunately, they did not tell me this until I paid 2 years' worth of tuition to Harvard Business School.)

GENRE
Health & Well-Being
RELEASED
2009
1 April
LANGUAGE
EN
English
LENGTH
33
Pages
PUBLISHER
College of American Pathologists
SIZE
262.6
KB

More Books by Archives of Pathology & Laboratory Medicine

Unsatisfactory Reporting Rates: 2006 Practices of Participants in the College of American Pathologists Interlaboratory Comparison Program in Gynecologic Cytology (Cap Laboratory Improvement Programs) (Survey) Unsatisfactory Reporting Rates: 2006 Practices of Participants in the College of American Pathologists Interlaboratory Comparison Program in Gynecologic Cytology (Cap Laboratory Improvement Programs) (Survey)
2009
Bernard-Soulier Syndrome: An Inherited Platelet Disorder (Report) Bernard-Soulier Syndrome: An Inherited Platelet Disorder (Report)
2007
Poorly Differentiated Gastroenteropancreatic Neuroendocrine Carcinoma Associated with X-Linked Hyperimmunoglobulin M Syndrome (Case Report) (Disease/Disorder Overview) Poorly Differentiated Gastroenteropancreatic Neuroendocrine Carcinoma Associated with X-Linked Hyperimmunoglobulin M Syndrome (Case Report) (Disease/Disorder Overview)
2008
The Evolving Revolution of Pathology's Role in Renal Medical Diseases (Special Section--Renal Pathology) (Report) The Evolving Revolution of Pathology's Role in Renal Medical Diseases (Special Section--Renal Pathology) (Report)
2009
The Value of Monitoring Human Papillomavirus DNA Results for Papanicolaou Tests Diagnosed As Atypical Squamous Cells of Undetermined Significance: A College of American Pathologists Q-Probes Study of 68 Institutions (Report) The Value of Monitoring Human Papillomavirus DNA Results for Papanicolaou Tests Diagnosed As Atypical Squamous Cells of Undetermined Significance: A College of American Pathologists Q-Probes Study of 68 Institutions (Report)
2007
Laboratory Compliance with the American Society of Clinical Oncology/College of American Pathologists Guidelines for Human Epidermal Growth Factor Receptor 2 Testing: A College of American Pathologists Survey of 757 Laboratories (Cap Laboratory Improvement Programs) Laboratory Compliance with the American Society of Clinical Oncology/College of American Pathologists Guidelines for Human Epidermal Growth Factor Receptor 2 Testing: A College of American Pathologists Survey of 757 Laboratories (Cap Laboratory Improvement Programs)
2010